412 related articles for article (PubMed ID: 17635051)
1. Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.
Yamashita H; Matsumoto M
Regen Med; 2007 Jul; 2(4):447-55. PubMed ID: 17635051
[TBL] [Abstract][Full Text] [Related]
2. Modeling neurodegenerative diseases in vivo review.
von Bohlen Und Halbach O
Neurodegener Dis; 2005; 2(6):313-20. PubMed ID: 16909014
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.
Calì T; Ottolini D; Brini M
Biofactors; 2011; 37(3):228-40. PubMed ID: 21674642
[TBL] [Abstract][Full Text] [Related]
4. Genetic mouse models of parkinsonism: strengths and limitations.
Fleming SM; Fernagut PO; Chesselet MF
NeuroRx; 2005 Jul; 2(3):495-503. PubMed ID: 16389313
[TBL] [Abstract][Full Text] [Related]
5. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
6. [The pathogenesis of Parkinson's disease: a hint from insights of familial Parkinson's disease].
Hattori N; Kubo S
Rinsho Shinkeigaku; 2007 Nov; 47(11):774-8. PubMed ID: 18210796
[TBL] [Abstract][Full Text] [Related]
7. Neuronal pathology in Parkinson's disease.
Schulz JB; Falkenburger BH
Cell Tissue Res; 2004 Oct; 318(1):135-47. PubMed ID: 15365812
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
9. Heredity in Parkinson's disease: new findings.
Lev N; Melamed E
Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of Parkinson disease.
Eriksen JL; Wszolek Z; Petrucelli L
Arch Neurol; 2005 Mar; 62(3):353-7. PubMed ID: 15767499
[TBL] [Abstract][Full Text] [Related]
11. Glutathione--a review on its role and significance in Parkinson's disease.
Martin HL; Teismann P
FASEB J; 2009 Oct; 23(10):3263-72. PubMed ID: 19542204
[TBL] [Abstract][Full Text] [Related]
12. An ERcentric view of Parkinson's disease.
Mercado G; Valdés P; Hetz C
Trends Mol Med; 2013 Mar; 19(3):165-75. PubMed ID: 23352769
[TBL] [Abstract][Full Text] [Related]
13. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies in Parkinson's disease: what we have learned from animal models.
Valadas JS; Vos M; Verstreken P
Ann N Y Acad Sci; 2015 Mar; 1338():16-37. PubMed ID: 25515068
[TBL] [Abstract][Full Text] [Related]
15. Etiology and pathogenesis of Parkinson's disease.
Olanow CW; Tatton WG
Annu Rev Neurosci; 1999; 22():123-44. PubMed ID: 10202534
[TBL] [Abstract][Full Text] [Related]
16. Current perspective of mitochondrial biology in Parkinson's disease.
Ammal Kaidery N; Thomas B
Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
[TBL] [Abstract][Full Text] [Related]
17. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.
Schober A
Cell Tissue Res; 2004 Oct; 318(1):215-24. PubMed ID: 15503155
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the role of defective genes in Parkinson's disease.
Dawson TM
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S248-9. PubMed ID: 18267244
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of Parkinson's disease.
Gandhi S; Wood NW
Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.
Xiong N; Long X; Xiong J; Jia M; Chen C; Huang J; Ghoorah D; Kong X; Lin Z; Wang T
Crit Rev Toxicol; 2012 Aug; 42(7):613-32. PubMed ID: 22574684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
